ATG16L1 and hepatocellular carcinoma: Further corroborating our findings, Zhang et al. reported that miR-142-3p increases the susceptibility of HCC cells to sorafenib by downregulating autophagy-promoting genes ATG5 and ATG16L1, enhancing apoptosis and reducing cell proliferation [54].